Wednesday, February 15, 2012

Nature Chemical Biology Contents: March 2012 Volume 8 Number 3, pp 222 - 318

Nature Chemical Biology

TABLE OF CONTENTS

March 2012 Volume 8, Issue 3

Research Highlights
News and Views
Brief Communications
Articles
Corrigenda
Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement
NPG Asia Materials has re-launched!
Now publishing on nature.com, NPG Asia Materials has entered a new phase and is now publishing original research articles in addition to review papers. Read the Editorial and recent content, covering a wide range of topics in materials science.
Discover more about NPG Asia Materials: www.nature.com/am
 

Research Highlights

Top

Molecular recognition: Sphingomyelin in the groove | Structural biology: Kinase-phosphatase mashup | Antimicrobials: Channel closure | Virology: Cholesterol pass for HCV | Metals: Zinc stores | Domino reactions: Chiral cycloaddition | Rna editing: Following ADAR | Post-Translational modifications: Sulfhydration switch

News and Views

Top

Protein design: A metalloenzyme reloaded pp224 - 225
Birte Hocker
doi:10.1038/nchembio.800
Metal ions are frequently used in enzyme catalysis. The extension of computational methods to metalloenzyme redesign opens up new ways to construct enzymes with new functions.
Full Text | PDF
See also: Article by Khare et al.

Alternative DNA structures: G4 DNA in cells: itae missa estpp225 - 226
Jean-Louis Mergny
doi:10.1038/nchembio.793
Application of a synthetic DNA G-quadruplex ligand as a genome-wide probe has provided evidence for G-quadruplex DNA clusters in human cells.
Full Text | PDF
See also: Article by Rodriguez et al.

Protein folding: Chaperoning protein evolution pp226 - 228
Paolo De Los Rios and Pierre Goloubinoff
doi:10.1038/nchembio.791
Osmolytes that normally accumulate in cells to equilibrate osmotic stress are also called chemical chaperones because of their ability to stabilize native proteins in vitro. A recent paper shows that various chemical chaperones differently alter the cellular milieu and permit the appearance of osmolyte-specific protein mutant variants during evolution.
Full Text | PDF
See also: Article by Bandyopadhyay et al.

BCR-ABL signaling: A new STATus in CML pp228 - 229
Doriano Fabbro
doi:10.1038/nchembio.900
A combination of genetic and pharmacological approaches using mouse leukemia models show that STAT5 phosphorylation is one of the major drivers of the proliferation of Philadelphia chromosome-positive (BCR-ABL-positive or Ph+) chronic myeloid leukemia. Once BCR-ABL expression has been established, JAK2 is required only for lymphoid cell transformation, not for the maintenance of the lymphoid or myeloid leukemia.
Full Text | PDF
See also: Article by Hantschel et al.

Histone deacetylation: IP4 is an epigenetic coregulator pp230 - 231
Tatiana G Kutateladze
doi:10.1038/nchembio.795
Inositol tetraphosphate is required for both the incorporation of the histone deacetylase HDAC3 into a repressive complex and its enzymatic activity.
Full Text | PDF

Chemical Biology
JOBS of the week
Postdoctoral Fellow
Yuh Min Chook, Ph.D., UT Southwestern
Scientist / Cell Biology OR Chemical Engineering
Kelly Scientific Resources
MRes in Chemical Biology of Crop Sustainability & Protection
Imperial College London
Interdisciplinary MRC PhD Programme Funded by the Medical Resarch Council (MRC) 'Macromolecular machines of biomedical significance'
Birkbeck College
More Science jobs from
Chemical Biology
EVENT
Therapeutic Applications of Computational Biology and Chemistry (TACBAC) 2012
12-14 March 2012
Cambridge, UK
More science events from

Brief Communications

Top

Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin pp232 - 234
Gary J. Patti, Oscar Yanes, Leah P Shriver, Jean-Phillipe Courade, Ralf Tautenhahn, Marianne Manchester and Gary Siuzdak
doi:10.1038/nchembio.767



Untargeted metabolomics reveals a dysregulation of sphingolipid production during neuropathic pain exemplified by N,N-dimethylsphingosine, whose upregulation is involved in the generation of pain.
First paragraph | Full Text | PDF

Using transcriptome sequencing to identify mechanisms of drug action and resistance pp235 - 237
Sarah A Wacker, Benjamin R Houghtaling, Olivier Elemento and Tarun M Kapoor
doi:10.1038/nchembio.779



Selection of clones resistant to drugs in human cells, followed by massively parallel transcriptome sequencing of these clones and bioinformatics analyses to identify genes mutated with high frequency, allow for identification of direct targets and indirect resistance mechanisms of cytotoxic drugs.
First paragraph | Full Text | PDF

Articles

Top

Chemical chaperones assist intracellular folding to buffer mutational variations pp238 - 245
Anannya Bandyopadhyay, Kanika Saxena, Neha Kasturia, Vijit Dalal, Niraj Bhatt, Asher Rajkumar, Shuvadeep Maity, Shantanu Sengupta and Kausik Chakraborty
doi:10.1038/nchembio.768



Osmolytes act as chemical chaperones capable of directly assisting the folding of destabilizing mutations in proteins in vivo, with different osmolytes having distinct targets and thereby increasing the level of genetic variability.
Abstract | Full Text | PDF
See also: News and Views by De Los Rios & Goloubinoff

Evidence for dynamics in proteins as a mechanism for ligand dissociation pp246 - 252
Mary J Carroll, Randall V Mauldin, Anna V Gromova, Scott F Singleton, Edward J Collins and Andrew L Lee
doi:10.1038/nchembio.769



NMR and structural analyses of DHFR complexes with inhibitors of differing affinities define a model for ligand dissociation involving conformational switching and a new excited state that mediates the dissociation.
Abstract | Full Text | PDF | Chemical compounds

Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation pp253 - 261
Jessica E Rexach, Peter M Clark, Daniel E Mason, Rachael L Neve, Eric C Peters and Linda C Hsieh-Wilson
doi:10.1038/nchembio.770



Glycosylation is a well-known post-translational modification, but identifying specific roles for the attached glycans is often challenging. The identification and investigation of a new O-GlcNAc site on the transcription factor CREB provides insights into how glycosylation works together with phosphorylation to coordinate neural function.
Abstract | Full Text | PDF

Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis pp262 - 269
Mary Katherine Tarrant, Hee-Sool Rho, Zhi Xie, Yu Lin Jiang, Christopher Gross, Jeffrey C Culhane, Gai Yan, Jiang Qian, Yoshitaka Ichikawa, Tatsuji Matsuoka, Natasha Zachara, Felicia A Etzkorn, Gerald W Hart, Jun Seop Jeong, Seth Blackshaw, Heng Zhu and Philip A Cole
doi:10.1038/nchembio.771



Semisynthetic constructs of protein kinase CK2 incorporating nonhydrolyzable post-translational modifications now demonstrate the interplay between phosphorylation and glycosylation in regulating CK2 stability, controlling substrate specificity and modifying interactions with regulatory proteins.
Abstract | Full Text | PDF

Spatiotemporal resolution of the Ntla transcriptome in axial mesoderm development pp270 - 276
Ilya A Shestopalov, Cameron L W Pitt and James K Chen
doi:10.1038/nchembio.772



The combination of a caged morpholino and a photoactivated fluorophore, allowing isolation of targeted cells by FACS, and subsequent transcriptional profiling reveals new and temporally distinct targets for Ntla during notochord development in zebrafish.
Abstract | Full Text | PDF

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia pp277 - 284
Jolanta Grembecka, Shihan He, Aibin Shi, Trupta Purohit, Andrew G Muntean, Roderick J Sorenson, Hollis D Showalter, Marcelo J Murai, Amalia M Belcher, Thomas Hartley, Jay L Hess and Tomasz Cierpicki
doi:10.1038/nchembio.773



MLL fusion genes often encode leukemogenic proteins that depend on interaction with menin, a component of the MLL SET1-like histone methyltransferase complex. MI-2 and MI-3 are the first small molecules that can block menin–MLL fusion protein interaction and their oncogenic effects in cells.
Abstract | Full Text | PDF | Chemical compounds

BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia pp285 - 293
Oliver Hantschel, Wolfgang Warsch, Eva Eckelhart, Ines Kaupe, Florian Grebien, Kay-Uwe Wagner, Giulio Superti-Furga and Veronika Sexl
doi:10.1038/nchembio.775



Although JAK2 inhibitors were proposed to be beneficial in chronic myeloid leukemia, myeloid transformation and STAT5 activation in BCR-ABL–positive leukemias are JAK2 independent. Mechanistic investigations reveal that certain JAK2 inhibitors act via off-target inhibition of BCR-ABL.
Abstract | Full Text | PDF
See also: News and Views by Fabbro

Computational redesign of a mononuclear zinc metalloenzyme for organophosphate hydrolysis pp294 - 300
Sagar D Khare, Yakov Kipnis, Per Jr Greisen, Ryo Takeuchi, Yacov Ashani, Moshe Goldsmith, Yifan Song, Jasmine L Gallaher, Israel Silman, Haim Leader, Joel L Sussman, Barry L Stoddard, Dan S Tawfik and David Baker
doi:10.1038/nchembio.777



Metals serve as unique structural and functional elements in biology, providing a wealth of reactivities not available in a wholly proteinogenic active site. The computational redesign and directed evolution of zinc enzymes to create a phosphotriesterase provides insights into how these elements can be utilized in the development of new functions.
Abstract | Full Text | PDF
See also: News and Views by Hocker

Small-molecule–induced DNA damage identifies alternative DNA structures in human genes pp301 - 310
Raphaël Rodriguez, Kyle M Miller, Josep V Forment, Charles R Bradshaw, Mehran Nikan, Sébastien Britton, Tobias Oelschlaegel, Blerta Xhemalce, Shankar Balasubramanian and Stephen P Jackson
doi:10.1038/nchembio.780



Identifying DNA sequences that adopt alternative structures within the context of genomic DNA presents a major challenge. Pyridostatin, a G-quadruplex–specific chemical probe, was shown to induce DNA damage at specific genomic sites, including the proto-oncogene SRC, leading to cell cycle arrest in human cancer cells.
Abstract | Full Text | PDF | Chemical compounds
See also: News and Views by Mergny

Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase pp311 - 317
Tracy L Keller, Davide Zocco, Mark S Sundrud, Margaret Hendrick, Maja Edenius, Jinah Yum, Yeon-Jin Kim, Hak-Kyo Lee, Joseph F Cortese, Dyann F Wirth, John David Dignam, Anjana Rao, Chang-Yeol Yeo, Ralph Mazitschek and Malcolm Whitman
doi:10.1038/nchembio.790



Halofuginone was recently shown to inhibit the differentiation of T helper 17 (TH17) cells, which are associated with autoimmune diseases. The demonstration that halofuginone inhibits prolyl-tRNA synthetase activity explains the observed activation of the amino acid response pathway in TH17 cells and identifies amino acid restriction pathways as potential drug targets in inflammatory disease.
Abstract | Full Text | PDF | Chemical compounds

Corrigenda

Top

Identifying polyglutamine protein species in situ that best predict neurodegeneration p318
Jason Miller, Montserrat Arrasate, Elizabeth Brooks, Clare Peters Libeu, Justin Legleiter, Danny Hatters, Jessica Curtis, Kenneth Cheung, Preethi Krishnan, Siddhartha Mitra, Kartika Widjaja, Benjamin A Shaby, Gregor P Lotz, Yvonne Newhouse, Emily J Mitchell, Alex Osmand, Michelle Gray, Vanitha Thulasiramin, Frederic Saudou, Mark Segal, X William Yang, Eliezer Masliah, Leslie M Thompson, Paul J Muchowski, Karl H Weisgraber and Steven Finkbeiner
doi:10.1038/nchembio0312-318a
Full Text | PDF

Dafadine inhibits DAF-9 to promote dauer formation and longevity of Caenorhabditis elegans  p318
Genna M Luciani, Lilia Magomedova, Rachel Puckrin, Malene L Urbanus, Iain M Wallace, Guri Giaever, Corey Nislow, Carolyn L Cummins and Peter J Roy
doi:10.1038/nchembio0312-318b
Full Text | PDF

Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors p318
Alexander Adibekian, Brent R Martin, Chu Wang, Ku-Lung Hsu, Daniel A Bachovchin, Sherry Niessen, Heather Hoover and Benjamin F Cravatt
doi:10.1038/nchembio0312-318c
Full Text | PDF

Top
Advertisement


Scientific American monthly table of contents e-alerts
Sign up today!


Scientific American has been reporting on unique insights about inspiring developments in science and technology for more than 165 years. With an expertise for pinpointing emerging trends, in every issue Scientific American provides a greater understanding of current events and issues worldwide.

The Scientific American monthly table of contents e-alerts provides you with an overview of what is published in the latest issue.

Sign up today to start receiving your e-alerts directly to your desktop.

 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: